Phase 4 IOP Signals Associated With ILUVIEN®
NCT02424019
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
153
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetic Macular Edema (DME)
Interventions
DRUG:
ILUVIEN 0.19 MG
Sponsor
Alimera Sciences